US Bancorp’s Tema Oncology ETF CANC Stock Holding History

US Bancorp’s Portfolio CANC Stock Details CANC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.7K	Buy	+600	New	+$22.7K	﹤0.01%	3115

Other funds holding CANC

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

PIA

Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return

OIM

Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WWM

WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

US Bancorp's CANC Position: Q2 2026 in Review

US Bancorp opened a new position in Tema Oncology ETF (CANC) in Q2 2026: 600 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #3115 among its holdings.

15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

US Bancorp held 600 shares of Tema Oncology ETF worth $24.7K as of Q2 2026.
Tema Oncology ETF was a new US Bancorp position in Q2 2026.
Tema Oncology ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3115 holding.
15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.